Pharmaceutical Business Review
Anonymous User | Login

Sanofi-Aventis Presents New R&D Model Project

Published: 30-Jun-2009

Model aims to transform R&D and increase innovation

Sanofi-Aventis has presented its new R&D model project. The model, which aims to transform R&D and increase innovation, is the first step of the group’s new strategy which was presented in February 2009 by the CEO of Sanofi-Aventis, Christopher Viehbacher.

 

Christopher Viehbacher said: “The objective of this new R&D model is to propose innovative solutions that respond to specific, unmet needs of patients and continue our success in a very competitive international environment.”

 

“It is centered on the real needs of patients, the development of scientific networks and openness toward outside entities to strengthen creativity, and a flexible and entrepreneurial approach to research,” he added.

 

Marc Cluzel, Senior Vice President, Research and Development, Sanofi-Aventis, said: “Tomorrow’s research will be carried out through networks. We will be open to knowledge from outside sources, becoming a key partner. We need to reinvent R&D.

Mail sent successfully

Tell your friend about this article


Please enter a valid email address

Please enter your name

Please enter the mail body


Your Name: *
Your Email: *
Friend's Email: *
Email Body: *
 

Suppliers To This Sector

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Aris Global

Integrated Software Solutions and Services for Life Sciences ...

Treff

Custom Moulded Plastic Parts ...

IRW

Full-Service Nordic Clinical Research Organisation (CRO) ...

Sartorius Group

Laboratory and Process Technology Provider ...

Bioceros

Pre-Clinical Development of Monoclonal Antibodies and Generation of GMP-Ready Proteins ...

TOPRA

Healthcare Regulatory Affairs ...

White Papers

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Water Treatment

From the control room to the downstream processing area and with an eye on utilities servi ...

A Vaccinne Bioassay Case Study – A Successful Strategic Outsourcing Model

Increasingly, pharma and biotech firms are searching for new drivers of revenue and profit ...

USB HotStart-IT for Real Time PCR

USB® Products from Affymetrix have a long-standing reputation in the life science marketpl ...

Enabling Drug Delivery Deal Making

Transdermal drug delivery: Time for a closer look. To find out more download this free whi ...

Automating Training Control Processes to Comply with FDA Requirements

Well-managed training programs minimize the risk of non-compliance and improve product qua ...

TNO Pharma Services: From Discovery to the Clinic

Our kinetics & metabolism experts can help you select and further develop your candidate d ...

Related Companies

AstraZeneca PLC

AstraZeneca PLC (AstraZeneca) is a leading pharmaceuticals company engaged in the desig ...

Boehringer Ingelheim GmbH

Boehringer Ingelheim GmbH (Boehringer) is a group of companies engaged in the research, ...

Merck & Co., Inc.

Merck & Co., Inc. (Merck) is a global research-driven pharmaceutical company engaged in ...

Abbott Laboratories

Abbott Laboratories (Abbott) is a global health care company. It is principally engaged ...

GlaxoSmithKline plc

GlaxoSmithKline plc (GSK) is a is a United Kingdom-based pharmaceutical, biological, a ...

Suppliers Product News

No items to display

Free Newsletter Sign-up

Sign up, and we will send you a free Pharmaceutical report on “ Combination Products – Evolution of the Medical Equipment Industry” from GlobalData worth $750

Please enter a valid email address